Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0WW2D
|
||||
| Former ID |
DNC011313
|
||||
| Drug Name |
NSC-356819
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H16N6O
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)N=NC2=CC(=NNC3=CC=C(C=C3)C(=N)N)C(=O)C=C2
|
||||
| InChI |
1S/C19H16N6O/c20-19(21)13-6-8-15(9-7-13)23-25-17-12-16(10-11-18(17)26)24-22-14-4-2-1-3-5-14/h1-12,23H,(H3,20,21)/b24-22?,25-17-
|
||||
| InChIKey |
KKIMPPHHDOFHIQ-YUOZWSOOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NRH dehydrogenase [quinone] 2 | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. Epub 2010 Oct 21.In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.